Genprex, Inc. CEO discusses how their “Immunogene Therapy” Drug REQORSA, Modulates Apoptosis
Genprex’s President and CEO, Rodney Varner, sits down with CEO/CFO Magazine to talk about Genprex, how it is reprogramming the course of cancer and diabetes and key catalysts in the next 6-12 months.
original article: Genprex, Inc. | Rodney Varner | Gene Therapy Cancer (ceocfointerviews.com)